Hillhouse Capital is a global investment firm that focuses on long-term, fundamental research-driven equity investments across all stages, from seed to buyouts, in both public and private markets. The firm primarily targets sectors such as consumer, TMT, industrials, and healthcare, with a strategy centered on partnering with strong management teams to drive value creation through operational improvements and digital transformation.
Deal activity increased 300% year-over-year (4 deals in the last 12 months). Average disclosed round size is $340.7M (across 43 rounds with reported amounts).
Portfolio
47
Fund Size
$70.7B
Top Stage
Series C
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
47 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Growth | $70M | Feb 2026 | |
| Series A | $52M | Feb 2026 | |
| Series B | $85M | Jan 2026 | |
| Series F | $300M | May 2025 | |
| Series B | $45M | Sep 2024 | |
| Series B | $150M | Apr 2023 | |
| Series A | $22M | Jul 2022 | |
| Pre-Seed | $2.5M | Apr 2022 | |
| Series C | $128M | Sep 2021 | |
| Series C | $350M | Jul 2021 | |
| Series A | $150M | Jun 2021 | |
| Series F | $360M | Jan 2021 | |
| Series E | $515M | Dec 2020 | |
| CClassIn | Series C | $265M | Dec 2020 |
| Series C | $150M | Dec 2020 | |
| MManbang | Growth | $1.7B | Nov 2020 |
| Series G | $2.2B | Oct 2020 | |
| Growth | $418M | Sep 2020 | |
| Series C | $500M | Jul 2020 | |
| EEverest Medicines | Series C | $310M | Jun 2020 |
| Seed | $13.2M | Jan 2020 | |
| Series B | $120M | Aug 2019 | |
| KKurly | Series D | $113M | May 2019 |
| TTrumid Financial | Series C | $60M | May 2019 |
| Series B | $40M | May 2019 |
Page 1 of 2
Top Co-Investors
Tencent Investment9 shared
Sequoia China9 shared
Sequoia Capital6 shared
GGV Capital5 shared
SoftBank Vision Fund4 shared
Tiger Global Management3 shared
Coatue Management3 shared
DST Global3 shared
Ribbit Capital3 shared
GIC3 shared
OrbiMed3 shared
Cormorant Asset Management3 shared
Temasek Holdings3 shared
Boyu Capital3 shared
IDG Capital3 shared
Lilly Asia Ventures3 shared
Aspex Management2 shared
5Y Capital2 shared
Eight Roads Ventures2 shared
Greenoaks Capital2 shared
Last updated: 10 April 2026
